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ABSTRACT The ability of tryptophan tRNA (tRNATrP) to
initiate reverse transcription of the 70S RNA of avian RNA
tumor viruses suggested that the reverse transcriptase (RNA-
dependent DNA polymerase; deoxynucleosidetriphosphate:
DNA deoxynucleotidyltransferase; EC 2.7.7.7) might have a
specific binding site for the tRNA. A complex of tRNATrP and
the avian myeloblastosis virus reverse transcriptase has been
demonstrated using chromatography on Sephadex G-100 col-
umns. Of all the chicken tRNA's, only tRNATrP and a
tRNA4Met bind to the enzyme with high enough affinity to be
selected from a mixture of the chicken cell tRNAs. The abili-
ty of tRNATIP to change the sedimentation rate of the en-
zyme indicates that tRNATrP is not binding to a contaminant
in the enzyme preparation. Treatment of the enzyme with
monospecific antibody to reverse transcriptase prevented
binding of tRNA as well as inhibited the DNA polymerase
activity of the enzyme. The ability of reverse transcriptase to
utilize tRNATrP as a primer for DNA synthesis, therefore, ap-
pears to involve a highly specific site on the enzyme.
In vitro synthesis of DNA by the DNA polymerase (deoxy-
nucleosidetriphosphate:DNA deoxynucleotidyltransferase,
EC 2.7.7.7) found in virions of RNA tumor viruses (reverse
transcriptase) is a primer-dependent reaction (1, 2). When
the "70S" RNA from virions is used as a template, a low-
molecular-weight RNA of the 70S complex acts as primer
(3-5). For Rous sarcoma virus, this RNA has been shown to
be identical to a cellular tryptophan tRNA (tRNATrP) that is
called "spot 1 RNA" after separation by 2-dimensional gel
electrophoresis (6-9). Such tRNATrP has been isolated from
three sources: 70S RNA, free 4S RNA from virions of Rous
sarcoma virus, and normal chicken embryo fibroblasts (4, 5,
8).
Although other tRNAs are found associated with 70S RNA
and as free 4S RNA in virions (10), 90% of the DNA mole-
cules copied from 70S RNA have been shown to be initiated
using tRNATrP as a primer (4). Part of its ability to act as
primer may result from the tight association of tRNATrP
with the 35S RNA subunits of the 70S RNA; of the 70S-asso-
ciated tRNAs, tRNATrP requires the highest temperature for
removal from the 35S RNA (4, 11). The tRNATrP also ap-
pears to be able to anneal back to 35S RNA (12, 13). The as-
sociation of tRNATrP with 35S RNA, however, is not suffi-
cient to explain its ability to act as primer for the reverse
transcriptase because, in general, the enzyme uses DNA effi-
ciently as primer but utilizes RNA primers poorly (1, 14).
The apparent selectivity of reverse transcriptase for
tRNATrP over other 70S-associated tRNAs and the poor rate
of priming of reverse transcriptase by RNA homopolymers
led us to investigate whether there might be a specific bind-
ing site on the reverse transcriptase for tRNATrP.
Abbreviation: AMV, avian myeloblastosis virus.,
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Using an assay for high-affinity binding sites, we have
been able to demonstrate specific binding of tRNATrP to the
reverse transcriptase of avian myeloblastosis virus (AMV).
MATERIALS AND METHODS
Materials. AMV reverse transcriptase was purified by se-
quential chromatography on columns of DEAE-Sephadex
and phosphocellulose (15). The phosphocellulose fraction
was further purified on a DNA-cellulose column (16). The
enzyme preparation gave only two bands after electropho-
retic separation on 10% sodium dodecyl sulfate-polyacryl-
amide gels; these migrated as do the previously character-
ized a and ,B subunits of AMV reverse transcriptase (17). An-
tiserum to AMV reverse transcriptase was obtained from Dr.
R. Nowinski, Madison, Wisc. (18). The IgG fraction was pu-
rified from serum as described (19). Chicken liver tRNA and
chicken liver aminoacyl tRNA synthetases were prepared
following published procedures (20-22). Purified Escherich-
ia coli tRNATyr, E. coli tRNASer, and yeast tRNAPhe were
gifts from Dr. U. L. RajBhandary and M. Silberklong.
(dG)12 18 and (dT)12-18 were purchases from Collaborative
Research Corp. These polynucleotides were labeled at their
5'-end using polynucleotide kinase and ['y-32P]ATP (23). Ra-
dioactive nucleotides and amino acids were products of New
England Nuclear Corp. Sephadex G-100 was obtained from
Pharmacia Corp.
Preparation of 32P-Labeled RNAs. Cultures of chicken
embryo fibroblasts infected with Schmidt-Ruppin D Rous
sarcoma virus or Carr-Zilber associated virus were obtained
from Dr. H. M. Temin. The cells were radioactively labeled
in 100 mm diameter dishes with [32P]orthophosphate as de-
scribed previously (7), using 1-2 mCi of [32P]orthophosphate
per ml of medium. After 48 hr of labeling, virus was har-
vested from the medium by centrifugation and RNA was ex-
tracted without further purification (7). Viral RNA was frac-
tionated into 70S and "free" 4S RNA by centrifugation
through sucrose gradients (7). The 4S RNA was precipitated
with 2 volumes of ethanol, resuspended in 0.05 M NaCl,
0.01 M Tris-HCI, pH 7.8, 0.01 M MgCl2, and was applied to
a 1 ml column of DEAE-Sephadex A-50 (Pharmacia). After
successive washes with 0.05 M NaCl and 0.3 M NaCl the
RNA was eluted from the column with 1 M NaCl in the
same buffer and concentrated by ethanol precipitation.
After virus was harvested, the labeled cells were washed
twice with 5 ml of TSE buffer (0.02 M Tris-HCI, pH 7.8; 0.1
M NaCl; 1 mM EDTA) at room temperature. Cells were
then treated on the culture plates with 0.5% sodium dodecyl
sulfate in TSE buffer, 1 ml/10 cm plate for 15 min at room
temperature. The suspension was carefully removed from
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the plates to avoid shearing of DNA and 0.25 volume of 5 M
NaCl was added. After storage overnight, the precipitate
was removed by centrifugation at 15,000 X g for 20 min.
The supernatant was extracted twice with phenol and twice
with chloroform/isoamyl alcohol (24:1). Nucleic acids were
precipitated with 2 volumes of ethanol at -20° in the pres-
ence of 100 ,g of carrier RNA (phenol-extracted Sigma type
IV yeast RNA). RNA was purified by chromatography on
DEAE-Sephadex as described above, followed by centrifu-
gation in a 5-20% sucrose gradient in TSE buffer containing
0.5% Sarkosyl (Geigy) at 49,000 rpm, 2 hr, 40 in a Beckman
SW 50.1 rotor.
The. individual tRNA species were purified from virion-
associated or cellular tRNA using 2-dimensional gel electro-
phoresis as described previously (7).
Unlabeled tRNATrP from chicken liver was purified as de-
scribed elsewhere (9). E. coli 32P-labeled 5S RNA and 4.5S
RNA were prepared as described previously (6) using the
hot sodium dodecyl sulfate method of Bremer and Yuan
(24).
Binding Assay. For assay of binding, the reaction mixture
(100-200 ,l) contained 50 mM Tris-HCl (pH 8.3), 60 mM
NaCl, 10 mM 2-mercaptoethanol, 10 mM MgCl2, 5% (v/v)
glycerol, 0.1% Nonidet P-40, [32P]RNA as indicated, and 50
to 150 enzyme units of reverse transcriptase. After 10 min
incubation at 20, the reaction mixtures were chromato-
graphed on columns of Sephadex G-100 (0.6 X 23 cm) pre-
equilibrated at 40 with buffer A (0.1 M potassium phos-
phate, pH 7.5, 5 mM MgC12, 10 mM 2-mercaptoethanol,
10% (v/v) glycerol, 0.1 mM EDTA, and 0.1% Nonidet P-40).
The column was eluted with buffer A. Fractions of 0.17 ml
were collected and 25-50 ,ul portions of each fraction were
assayed for reverse transcriptase activity; 60-70% of added
enzymatic activity was routinely recovered in the fractions.
Portions of each of the fractions were also used for determi-
nation of [32P]RNA.
Enzyme Assay. Reaction mixtures (100 Al) contained 50
mM Tris-HCl (pH 8.3), 6 mM MgCl2, 0.1 mM [3H]dGTP
(100 cpm/pmol), 2 Mg of poly(C), 0.5 Mig of (dG)1218, 5 mM
dithiothreitol, and 25-50 Ml of fractions from the Sephadex
G-100 columns or glycerol gradients. Reactions were incu-
bated for 30 min at 37'. One enzyme unit was defined as
the amount needed to catalyze the incorporation of 1 pmol
of dGMP into polymer in 1 min. The assay for E. coli DNA
polymerase I was as described for reverse transcriptase but 1
Mg of poly(dA) and 1 Mg of (dT)12_18 were used as the tem-
plate and primer and the incorporation from [3H]dTTP (60
cpm/pmol) was followed.
RESULTS
Binding of tRNATrP to Reverse Transcriptase. To study
its binding to the AMV reverse transcriptase, we chromato-
graphed [32P]tRNATrP purified from chicken cells or from
virions of an avian leukosis virus through Sephadex G-100
with or without added reverse transcriptase. When chroma-
tographed by itself, tRNATrP eluted from the column as an
included peak of radioactivity (Fig. 1A). When mixed with
reverse transcriptase, most of the [32P]tRNATrP eluted in the
excluded volume and no peak of included tRNATrP was evi-
dent (Fig. 1B). The reverse transcriptase, a protein of
160,000 daltons (17), was found in the excluded volume
whether or not tRNATrP was added. About 30% of the 32p in
a preparation of [32P]tRNATrP from chicken cells also eluted
in the excluded volume from Sephadex G-100 when mixed
with reverse transcriptase (Fig. 1C) but it was entirely in-
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Fig. 1. Effect of reverse transcriptase on gel filtration pattern
of [32P]tRNATh). Binding reactions and chromatography on Seph-
adex G-100 columns were carried out as described in Materials
and Methods. (A) Cell [32PjtRNATrP (3600 cpm), arrow marks the
excluded volume of the column; (B) virion [32P~tRNATh)' (7300
cpm) and reverse transcriptase (50 units), and (C) cell
[32P~tRNATh) (4100 cpm) and reverse transcriptase (50 units).
0-_0 [32P]tRNA; * ----@, reverse transcriptase activity.
cluded in the column if the enzyme was not added (not
shown). This gel filtration assay is, therefore, capable of de-
tecting a complex between the reverse transcriptase and
*tRNATrP. Attempts at using a Millipore filter binding assay
have been unsuccessful.
Four different preparations of tRNATrP from chicken cells
were studied for their binding to reverse transcriptase; about
Table 1. Binding of different RNA species
to reverse transcriptase
Bound*
32P-labeled Unbound* % of
polynucleotide cpm cpm total
Cell tRNAThp
without enzyme 3,600 0 0
Cell tRNATrPt 3,190 2,330 42
Cell tRNATrPt 2,040 1,030 34
Cell tRNATrPt 3,150 1,440 32
Cell tRNATrpt 4,490 1,810 29
Spot 2 virion tRNA 7,940 330 4
Spots 4 and 5
virion tRNA 9,700 460 4
Chicken 5S RNA 9,620 500 5
E. coli tRNATYr 7,010 0 0
E. coli tRNASer 7,470 620 7
Yeast tRNAPhe 9,170 560 5
E. coli4.5S RNA 5,380 570 9
E. coli 5S RNA 2,070 80 4
(dG)12 ,8 74,490 490 0.6(dT)12-18 64,230 690 1
* Radioactivity in the excluded volume of a Sephadex G-100 col-
umn was considered "bound" to reverse transcriptase; radioactiv-
ity in the included volume was considered "unbound". Fifty units
of reverse transcriptase were used in these assays.
t 32P spot 1 from three different preparations of chick embryo fibro-
blasts.
t Twenty-fold less enzyme (2.5 units) was added in this reaction.
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FIG. 2. Effect of reverse transcriptase on gel filtration pattern
of unfractionated tRNA. (A) Cell [32P]tRNA (4.2 X 106 cpm). (B)
Cell [32P]tRNA (10.6 X 106 cpm) and reverse transcriptase (150
units); (C) [32P]tRNA from virions of Schmidt-Ruppin D Rous
sarcoma virus (14,600 cpm); (D) [32P]tRNA from Schmidt-Ruppin
D Rous sarcoma virus (63,000 cpm) and reverse transcriptase (150
units). The excluded and included volumes from the columns were
pooled separately for analysis by polyacrylamide gel electrophore-
sis (see Fig. 3). Symbols as in Fig. 1.
35% of each tRNATrP preparation bound to the enzyme as
measured by the gel filtration assay (Table 1). Using 20-fold
less enzyme than in standard assays reduced binding only
slightly (Table 1) so the reactions appeared to be in enzyme
excess. To determine whether the fraction of tRNATrP that
would not bind to the enzyme was different from the bound
fraction, ribonuclease T1 digests of the [32P]RNA in the in-
cluded and excluded volumes of the Sephadex G-100 col-
umn in Fig. IC were fractionated by the methods of Sanger
et al. (25) and their fingerprints were compared. The RNA
preparations gave identical fingerprints and both fractions
appeared to be greater than 90% pure tRNATrP (data not
shown).
Specificity of Binding. A variety of purified RNAs have
been investigated for their ability to bind to AMV reverse
transcriptase. Three other tRNAs from virions of Rous sarco-
ma virus were tested and none showed significant binding
(Table 1). Various E. coli or yeast tRNAs and E. coli or
avian 5S RNAs did not bind detectably. Neither oligo(dT)
nor oligo(dG) bound significantly to the enzyme even
though they act as primers for the appropriate RNA tem-
plates (1).
Selection of tRNATrP by Reverse Transcriptase. The ap-
parent specificity of reverse transcriptase for tRNATrP sug-
gested that it might select only tRNATrP from a mixture of
virion-associated or chicken cell tRNAs. Therefore, unfrac-
tionated [32P]tRNA from chicken embryo cell cultures or
from Schmidt-Ruppin Rous sarcoma virus was mixed with
reverse transcriptase at a ratio calculated to produce an ap-
proximate molar equivalence of enzyme protein to tRNATrP.
All but about 2% of the cell tRNA preparation was included
by the Sephadex G-100 column (Fig. 2A) and mixing reverse
transcriptase with the tRNA increased the RNA in the ex-
cluded volume only slightly (Fig. 2B). Increasing the ratio of
FIG. 3. Two-dimensional electrophoresis of cell or virion [32P]tRNA after gel filtration in the presence of reverse transcriptase, as de-
scribed in ref. 7. (a) Cell [32P]tRNA before binding reaction; (b) cell tRNA bound by reverse transcriptase (excluded volume; Fig. 2B); (c)
cell tRNA not bound by reverse transcriptase (included volume; Fig. 2B); (d) virion-associated [32P]tRNA before binding reaction; (e) virion
tRNA bound by reverse transcriptase (excluded volume; Fig. 2D); (f) virion tRNA not bound by reverse transcriptase (included volume; Fig.
2D).
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enzyme to tRNA did not increase the amount of bound
tRNA (data not shown). Thus, a small proportion of total
chick tRNA was bound to the enzyme. Of the virion-associ-
ated tRNA, little was excluded from the Sephadex G-100 in
the absence of enzyme (Fig. 2C) but 33% bound to the en-
zyme (Fig. 2D).
To examine whether any specific tRNA might have been
selected by the enzyme from chick tRNA, we analyzed the
excluded and included fractions from Fig. 2A and 2B by 2-
dimensional polyacrylamide gel electrophoresis (Fig. 3).
Total chick tRNA contains a large number of species of
tRNA separable by this method (Fig. Sa). The fraction of
tRNA appearing in the excluded volume of a Sephadex
G-100 column in the absence of added reverse transcriptase
was not enriched for any of these tRNA species (data not
shown). The fraction excluded from Sephadex in the pres-
ence of reverse transcriptase was greatly enriched for three
tRNA species (Fig. 3b). The major enriched species (arrow
in Fig. Sb) had the same mobility as tRNATrP, that is, it was
equivalent to "spot 1" in previous analyses (7). When it was
eluted from the gel and digested with ribonuclease T1, and
the digest was separated by the method of Sanger et al. (25),
its fingerprint was identical to that of tRNATrP. The finger-
prints of the two other tRNAs in Fig. Sb were similar to each
other and to that of "spot 6" (7). This tRNA appears to be
tRNA4Met based on its fingerprint and minor nucleotide
analysis of its oligonucleotides (26, 27). The 2-dimensional
electrophoretic profile of the tRNA not bound by reverse
transcriptase (Fig. Sc) was similar to that of whole tRNA; it
still contained some unbound tRNATrP as identified by the
fingerprint of the tRNA eluted from the region marked by
an arrow in Fig. Sc. It should be noted that the two spots
with low mobility in both dimensions in Fig. Sa were 5S
RNA and are absent from Fig. Sb and c probably because
they eluted between the two fractions pooled from the Se-
phadex columns (see Fig. 2).
Two-dimensional electrophoretic separation of the virion-
associated tRNAs (Fig. 3d), the fraction bound by reverse
transcriptase (Fig. Se), and the unbound fraction (Fig. Sf)
showed that the enzyme selected a portion of the virion-as-
sociated tRNAs. Again, tRNATrP was the major species
bound by the enzyme (arrow in Fig. Se) as determined by
fingerprint analysis. Some of the minor spots of bound tRNA
appeared to be tRNA4Met. Also, some tRNATrP was still pres-
ent in the unbound tRNA (arrow in Fig. Sf).
Rate Zonal Centrifugation of Reverse Transcriptase-
tRNA Complexes. To further characterize the complex be-
tween reverse transcriptase and tRNATrP, we measured the
sedimentation coefficient of the complex, using glycerol gra-
dients. The enzyme was detected in the gradients by its
DNA polymerase activity. The free enzyme had a sedimen-
tation coefficient of 7.2 S (Fig. 4A) by comparison to sedi-
mentation rate of a marker E. coli DNA polymerase I that
has a sedimentation coefficient of 5.8 S (22). Mixing of the
reverse transcriptase with a molar excess of unlabeled puri-
fied tRNATrP (0.5 gg) increased the sedimentation rate of
the enzyme to 9 S (Fig. 4B). Addition of unfractionated
chicken liver tRNA (60 ,ug) similarly increased the sedimen-
tation rate of the enzyme to 9 S (Fig. 4C). E. coli DNA poly-
merase I in the same gradients did not change its sedimenta-
tion rate upon addition of tRNA. To examine the effect of
reverse transcriptase on the sedimentation rate of tRNATrP,
we mixed [32P]tRNATrP (approximately 0.01 ,ug, 6800 cpm)
with the enzyme and analyzed by centrifugation. Most of
the enzymatic activity sedimented at the rate of free reverse
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FIG. 4. Sedimentation through glycerol gradients of mixture
of tRNATrP and reverse transcriptase. Reaction mixtures of 200 Ml
with 37.5 units of reverse transcriptase were prepared as in gel fil-
tration analysis. After 10 min incubation at 40, E. coli DNA poly-
merase I (Pol 1, 6 units, ref. 22) was added as a marker and the
mixtures were layered onto 5 ml of 20-40% v/v glycerol gradients
in 0.1 M potassium phosphate (pH 7.5), 5 mM MgCl2, 10 mM 2-
mercaptoethanol, 0.1% Nonidet P-40, and 0.1 mM EDTA. After
centrifugation for 26 hr at 46,000 rpm in an SW50.1 Spinco rotor,
the gradient was fractionated into 0.17 ml fractions and assayed
for reverse transcriptase, E. coli DNA polymerase I, and[32P]tRNA. (A) Reverse transcriptase alone; (B) reverse transcrip-
tase plus 0.5 ;tg of cell tRNATrP; (C) reverse transcriptase plus 60
,gg of total chicken liver tRNA; (D) reverse transcriptase plus 5000
cpm cell [32P]tRNATrP. *- - *, reverse transcriptase; o-o, E. coli
DNA polymerase I; 0-0 [32P]tRNA.
transcriptase because very little tRNATrP was added. Fifty-
two percent of the added [32P]tRNATrP sedimented at 9 S, in
a position corresponding to the unlabeled tRNATrP--enzyme
complex formed by adding excess tRNATrP. Unbound
[32P]RNA sedimented at 4 S. The ability of tRNATrP to in-
crease the sedimentation rate of reverse transcriptase may
explain the observation of Duesberg et al. (29) that reverse
transcriptase isolated from virions has a faster sedimentation
rate than the purified enzyme.
The ability of tRNATrP to increase the sedimentation rate
of reverse transcriptase indicates that the tRNA binding ac-
tivity of the enzyme preparation is not due to a contami-
nant. Furthermore, no tryptophanyl tRNA synthetase, the
most likely contaminant that could be responsible for the
binding (30), could be found in our enzyme preparations
(unpublished data). Also, anti-reverse transcriptase IgG pre-
pared from the serum of a rat immunized with pure AMV
reverse transcriptase (18), but not nonspecific IgG, inhibited
both DNA polymerase activity and the tRNATrP binding ac-
tivity (data not shown).
DISCUSSION
The ability to selectively bind tRNA adds another activity to
those already defined on the reverse transcriptase molecule.
These include a ribonuclease H activity (31, 32) and a DNA
polymerase able to copy both RNA and DNA (2). The DNA
polymerase activity presumably requires at least three sites
225-338 Biochemistry: Panet et al.
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(33): a template-binding site, a deoxyribonucleoside-triphos-
phate-binding site, and a site for recognition of the T3'-OH
group of a growing polydeoxyribonucleotide chain. Because
the sites involved in both ribonuclease H and DNA polymer-
ase activity do not have the necessary specificity, the
tRNATrP-binding site must be different from the others. Its
function could be to position the 3'-OH at the -C-C-A OH
end of the tRNA in the normal 3'-OH binding site, but more
detailed work will be necessary to elucidate the details of its
function in the initiation of DNA synthesis on 70S RNA.
From the present data and earlier reports it is evident that
tRNATrP has two critical specificities which allow it to func-
tion as the primer of the DNA copies of 70S RNA. It has af-
finity for a site or sites on both 35S RNA (12, 13) and on re-
verse transcriptase. The virus must have evolved to utilize
the tRNA in these two ways so as to provide a mechanism
for initiation of DNA synthesis. While there is still no evi-
dence that tRNATrP initiates reverse transcription in vivo,
existence of a high affinity site for tRNATrP on the enzyme
strongly argues that tRNATrP does initiate in vivo DNA syn-
thesis. Our present evidence relates only to avian viruses; the
binding properties of the reverse transcriptase from murine
viruses remain to be studied.
Many tRNA molecules occur in virions of RNA tumor vi-
ruses as "free" tRNA, that is, not bound in the 70S RNA
complex (10). The binding of the tRNATrP and tRNA4Met to
reverse transcriptase can explain why these tRNAs are found
in virions, but these two tRNA species represent only 30% of
the virion-associated tRNA (Fig. 2D) and the reason for in-
clusion of the other tRNA species still requires explanation.
Purified tRNATrP from chick embryo fibroblasts is only
partially bound to reverse transcriptase even when a large
excess of enzyme is used. No structural difference between
the bound and unbound fractions has as yet been detected.
It could be that conformational isomers of tRNATrP explain
the two fractions or that minor structural differences are
present. The clear separation of the bound and unbound
fractions after either Sephadex G-100 chromatography or
glycerol gradient centrifugation suggests that the binding af-
finity is very high and that dissociation of the tRNA-enzyme
complex during analysis is not responsible for the two frac-
tions.
The interaction of tRNATrP and reverse transcriptase is
reminiscent of the binding of tRNA to its cognate aminoacyl
tRNA synthetase (34). Both binding reactions occur rapidly
at low temperatures, can be analyzed by gel filtration, and
are very selective (34, 35). Both reverse transcriptase and
synthetase bind deacylated as well as aminoacylated tRNA
(unpublished results).
It was pointed out previously that the initiation of DNA
synthesis by a preformed RNA primer may occur in systems
other than the RNA tumor viruses (3). One possible way to
identify such primers would be to show binding of an RNA
to a cellular DNA polymerase.
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